Compounds > 4-aminobenzoic acid

4-aminobenzoic acid and alpha-aminopyridine

4-aminobenzoic acid has been researched along with alpha-aminopyridine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's2 (25.00)18.2507
2000's0 (0.00)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Birdsall, B; Burgen, AS; Roberts, GC1
Her, GR; Li, DT1
Sugimoto, Y; Yamada, J; Yoshikawa, T1
Esfandiari, A; Hawthorne, TA; Lunec, J; Nakjang, S1
Aptullahoglu, E; Esfandiari, A; Ho, YH; Lovat, P; Lunec, J; Mahdi, AK; Wang, N; Wu, CE1
Estey, EH; Percival, MM1
Bridgewood, C; Civelli, M; Facchinetti, F; Higham, A; Lea, S; Li, J; Metryka, A; Singh, D; Villetti, G1
Lea, S; Mathioudakis, AG; Singh, D1

Reviews

2 review(s) available for 4-aminobenzoic acid and alpha-aminopyridine

ArticleYear
Current treatment strategies for measurable residual disease in patients with acute myeloid leukemia.
    Cancer, 2019, Sep-15, Volume: 125, Issue:18

    Topics: Aminopyridines; Aniline Compounds; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Immunological; Azacitidine; Cytogenetic Analysis; Decitabine; Enzyme Inhibitors; Flow Cytometry; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Immunologic Factors; In Situ Hybridization, Fluorescence; Lenalidomide; Leukemia, Myeloid, Acute; Molecular Diagnostic Techniques; Neoplasm, Residual; Nivolumab; para-Aminobenzoates; Protein Kinase Inhibitors; Pyrazines; Pyrrolidines; Recombinant Fusion Proteins; Remission Induction; Transplantation, Homologous; Triazines; Triazoles

2019
Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease.
    Drugs, 2021, Volume: 81, Issue:16

    Topics: Administration, Inhalation; Aminopyridines; Animals; Benzamides; Cyclic AMP; Cyclopropanes; Humans; Inflammation; Isoquinolines; para-Aminobenzoates; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Pyrimidinones; Sulfonamides

2021

Other Studies

6 other study(ies) available for 4-aminobenzoic acid and alpha-aminopyridine

ArticleYear
Effects of coenzyme analogues on the binding of p-aminobenzoyl-L-glutamate and 2,4-diaminopyrimidine to Lactobacillus casei dihydrofolate reductase.
    Biochemistry, 1980, Aug-05, Volume: 19, Issue:16

    Topics: 4-Aminobenzoic Acid; 4-Aminopyridine; Aminobenzoates; Aminopyridines; Binding Sites; Glutamates; Kinetics; Lacticaseibacillus casei; Mathematics; NADP; Oxidation-Reduction; para-Aminobenzoates; Protein Binding; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Thermodynamics

1980
Linkage analysis of chromophore-labeled disaccharides and linear oligosaccharides by negative ion fast atom bombardment ionization and collisional-induced dissociation with B/E scanning.
    Analytical biochemistry, 1993, Volume: 211, Issue:2

    Topics: 4-Aminobenzoic Acid; Aminopyridines; Carbohydrate Conformation; Carbohydrate Sequence; Chromogenic Compounds; Disaccharides; Fluorescent Dyes; Mass Spectrometry; Molecular Sequence Data; Oligosaccharides; Spectrometry, Mass, Fast Atom Bombardment; Spectrophotometry, Ultraviolet

1993
p-Chloroamphetamine, a serotonin-releasing drug, elicited in rats a hyperglycemia mediated by the 5-HT1A and 5-HT2B/2C receptors.
    European journal of pharmacology, 1998, Oct-23, Volume: 359, Issue:2-3

    Topics: 4-Aminobenzoic Acid; Adrenal Medulla; Adrenalectomy; Aminopyridines; Animals; Blood Glucose; Dose-Response Relationship, Drug; Ergolines; Fenclonine; Hyperglycemia; Indoles; Ketanserin; Male; Methysergide; p-Chloroamphetamine; para-Aminobenzoates; Piperazines; Propranolol; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Ritanserin; Serotonin; Serotonin Agents; Serotonin Antagonists; Tropisetron

1998
Chemical Inhibition of Wild-Type p53-Induced Phosphatase 1 (WIP1/PPM1D) by GSK2830371 Potentiates the Sensitivity to MDM2 Inhibitors in a p53-Dependent Manner.
    Molecular cancer therapeutics, 2016, Volume: 15, Issue:3

    Topics: Aminopyridines; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 7; Catalysis; Cell Line, Tumor; Cell Survival; Dipeptides; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Humans; Imidazoles; Mutation; Neoplasms; para-Aminobenzoates; Piperazines; Protein Phosphatase 2C; Proteolysis; Proto-Oncogene Proteins c-mdm2; Pyrrolidines; Transcription, Genetic; Tumor Suppressor Protein p53; Ubiquitin

2016
Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma.
    British journal of cancer, 2018, 02-20, Volume: 118, Issue:4

    Topics: Aminopyridines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dipeptides; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Melanoma; Melanoma, Cutaneous Malignant; Mutagenesis, Site-Directed; para-Aminobenzoates; Phosphorylation; Piperazines; Protein Binding; Protein Phosphatase 2C; Protein Stability; Proto-Oncogene Proteins c-mdm2; Pyrrolidines; Skin Neoplasms; Tumor Suppressor Protein p53

2018
The modulatory effects of the PDE4 inhibitors CHF6001 and roflumilast in alveolar macrophages and lung tissue from COPD patients.
    Cytokine, 2019, Volume: 123

    Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Benzamides; Chemokine CCL2; Chemokine CCL4; Cyclopropanes; Female; Humans; Macrophages, Alveolar; Male; Middle Aged; para-Aminobenzoates; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Sulfonamides; Tumor Necrosis Factor-alpha

2019